Evidence map›Paper›PMID 34208101›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

LPS Primes Brain Responsiveness to High Mobility Group Box-1 Protein.

Verena Peek, Lois M Harden, Jelena Damm, Ferial Aslani, Stephan Leisengang, Joachim Roth, Rüdiger Gerstberger, Marita Meurer, Maren von Köckritz-Blickwede, Sabine Schulz and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Verena PeekInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University Giessen, 35392 Giessen, Germany.
Lois M HardenBrain Function Research Group, School of Physiology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg 2193, South Africa.
Jelena DammInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University Giessen, 35392 Giessen, Germany.
Ferial AslaniInstitute of Anatomy and Cell Biology of the Medical Faculty, Justus Liebig University, 35392 Giessen, Germany.
Stephan LeisengangInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University Giessen, 35392 Giessen, Germany.
Joachim RothInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University Giessen, 35392 Giessen, Germany.
Rüdiger GerstbergerInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University Giessen, 35392 Giessen, Germany.
Marita MeurerDepartment of Biochemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany and Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, 30559 Hannover, Germany.ORCID 0000-0001-9409-4922
Maren von Köckritz-BlickwedeDepartment of Biochemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany and Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, 30559 Hannover, Germany.ORCID 0000-0001-7712-9767
Sabine SchulzInstitute of Inorganic and Analytical Chemistry, Justus Liebig University Giessen, 35392 Giessen, Germany.ORCID 0000-0002-6561-5562
Bernhard SpenglerInstitute of Inorganic and Analytical Chemistry, Justus Liebig University Giessen, 35392 Giessen, Germany.
Christoph RummelInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University Giessen, 35392 Giessen, Germany.ORCID 0000-0001-5457-4390
Justus-Liebig-Universität Gießen · DEUniversity of Veterinary Medicine Hannover, Foundation · DEUniversity of the Witwatersrand · ZA

Funding

Deutsche Forschungsgemeinschaft SP314/13-1
6 · The paper itself

Abstract

High mobility group box (HMGB)1 action contributes to late phases of sepsis, but the effects of increased endogenous plasma HMGB1 levels on brain cells during inflammation are unclear. Here, we aimed to further investigate the role of HMGB1 in the brain during septic-like lipopolysaccharide-induced inflammation in rats (LPS, 10 mg/kg, i.p.). HMGB-1 mRNA expression and release were measured in the periphery/brain by RT-PCR, immunohistochemistry and ELISA. In vitro experiments with disulfide-HMGB1 in primary neuro-glial cell cultures of the area postrema (AP), a circumventricular organ with a leaky blood-brain barrier and direct access to circulating mediators like HMGB1 and LPS, were performed to determine the direct influence of HMGB1 on this pivotal brain structure for immune-to-brain communication. Indeed, HMGB1 plasma levels stayed elevated after LPS injection. Immunohistochemistry of brains and AP cultures confirmed LPS-stimulated cytoplasmatic translocation of HMGB1 indicative of local HMGB1 release. Moreover, disulfide-HMGB1 stimulation induced nuclear factor (NF)-κB activation and a significant release of interleukin-6, but not tumor necrosis factor α, into AP culture supernatants. However, only a few AP cells directly responded to HMGB1 with increased intracellular calcium concentration. Interestingly, priming with LPS induced a seven-fold higher percentage of responsive cells to HMGB1. We conclude that, as a humoral and local mediator, HMGB1 enhances brain inflammatory responses, after LPS priming, linked to sustained sepsis symptoms.

Indexed as

circumventricular organscytokineshigh mobility group box-1 proteinlipopolysaccharideseptic-like inflammation

Identifiers

PMID34208101
PMCPMC8230749
OpenAlexW3166897333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.